Sessa Capital Im, L.P. Lexicon Pharmaceuticals, Inc. Transaction History
Sessa Capital Im, L.P.
- $3.3 Billion
- Q2 2025
A detailed history of Sessa Capital Im, L.P. transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Sessa Capital Im, L.P. holds 3,000,000 shares of LXRX stock, worth $3.18 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
3,000,000Holding current value
$3.18 Million% of portfolio
0.09%Shares
1 transactions
Others Institutions Holding LXRX
# of Institutions
130Shares Held
226MCall Options Held
436KPut Options Held
138K-
Artal Group S.A. Luxembourg, N4136MShares$144 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$41.3 Million1.9% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$10.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.85MShares$9.38 Million0.0% of portfolio
-
Schonfeld Strategic Advisors LLC New York, NY4.58MShares$4.85 Million0.03% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $200M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...